Authorization to implement the merger plan between Klaria and Karessa granted by the Swedish Companies Registration Office
The Swedish Companies Registration Office (the “SCRO”) has granted Klaria Pharma Holding AB (publ) (”Klaria”) (Nasdaq First North Growth Market: KLAR) authorization to implement the merger plan for the merger between Klaria and Karessa Pharma Holding AB (publ) (”Karessa”).The SCRO is expected to register the merger on Friday March 6, 2020. In connection with the registration of the merger, Karessa will be dissolved and all its assets and liabilities will be transferred to Klaria. In connection with the registration of the merger by the SCRO the shareholders that are registered in the